Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human PGAM1 Anticorps:
anti-Rat (Rattus) PGAM1 Anticorps:
anti-Mouse (Murine) PGAM1 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal PGAM1 Primary Antibody pour ELISA, WB - ABIN262347
Chaneton, Hillmann, Zheng, Martin, Maddocks, Chokkathukalam, Coyle, Jankevics, Holding, Vousden, Frezza, OReilly, Gottlieb: Serine is a natural ligand and allosteric activator of pyruvate kinase M2. dans Nature 2012
Show all 3 Pubmed References
Human Polyclonal PGAM1 Primary Antibody pour ICC, IF - ABIN4345011
Liu, Cao, Zhang, Bergmeier, Qian, Akbar, Colvin, Ding, Tong, Wu, Hines, Chen: A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. dans Molecular cancer therapeutics 2012
Show all 2 Pubmed References
Human Monoclonal PGAM1 Primary Antibody pour ELISA, WB - ABIN562190
Kimura, Sakurai, Koumura, Yamada, Hayashi, Tanaka, Hozumi, Tanaka, Takemura, Seishima, Inuzuka: High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases. dans Journal of neuroimmunology 2010
Show all 2 Pubmed References
conformation and dynamics of the C-terminal region in human phosphoglycerate mutase 1
When BPGM (Montrer BPGM Anticorps) is knocked out, 1,3-BPG can directly phosphorylate PGAM1. In this case, PGAM1 phosphorylation and activity are decreased, but nevertheless sufficient to maintain normal glycolytic flux and cellular growth rate.
study provided the first evidence revealing a non-metabolic function of PGAM1 in promoting cell migration, and gained new insights into the role of PGAM1 in cancer progression.
Data show that tyrosine 26 phosphorylation enhances the binding of phosphoglycerate mutase 1 (PGAM1) to its substrates through generating electrostatic environment and structural features that are advantageous to the binding.
PGAM1 in promoting homologous recombination repair in tumor cell lines. Suggest potential therapeutic opportunity for PGAM1 inhibitors in combination with PARP (Montrer COL11A2 Anticorps) inhibitors in cancer treatment.
PGAM1 may be associated with the grade of glioma and be involved in the biological behavior of glioma cells. PGAM1 might be a novel therapeutic target in glioma.
PGAM1 correlates with spermatogenic dysfunction and affects the function of cell proliferation, apoptosis and migration.
Our finding showed that PGAM1 might serve as a promising therapeutic target for UBC (Montrer RPS27A Anticorps).
PGAM1 is highly expressed in clear cell renal cell carcinoma (Montrer MOK Anticorps) and correlated with clinicalpathological features, which may contribute to tumor formation and progression.
PGAM is acetylated at lysines 100/106/113/138 in its central region, and a member of the Sirtuin (Montrer SIRT1 Anticorps) family (class III deacetylase), SIRT2 (Montrer SIRT2 Anticorps), is responsible for its deacetylation.
9630033F20Rik may play an important role in muscle wasting and that it has a distinguished characterization of gene network.[9630033F20Rik]
histidine-phosphorylated PGAM1 correlated with expression of PKM2 (Montrer PKM2 Anticorps) in tumor tissues; decreased pyruvate kinase activity in PKM2 (Montrer PKM2 Anticorps)-expressing cells allows PEP (Montrer PREP Anticorps)-dependent histidine phosphorylation of PGAM1 and may provide an alternate glycolytic pathway
Phosphoglyceric acid mutase (EC 18.104.22.168) is widely distributed in mammalian tissues where it catalyzes the reversible reaction of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) in the glycolytic pathway (summary by Chen et al., 1974
BPG-dependent PGAM 1
, phosphoglycerate mutase 1
, phosphoglycerate mutase A, nonmuscle form
, phosphoglycerate mutase isozyme B
, phosphoglycerate mutase 1 (brain)
, uncharacterized protein LOC706211
, bisphosphoglycerate mutase 1a